Frank Kondrad - NRBO Old VP Devel
| NRBODelisted Stock | USD 1.89 0.11 5.50% |
Insider
Frank Kondrad is VP Devel of NRBO Old
| Phone | 857 702 9600 |
| Web | https://www.neurobopharma.com |
NRBO Old Management Efficiency
The company has return on total asset (ROA) of (0.7435) % which means that it has lost $0.7435 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6076) %, meaning that it created substantial loss on money invested by shareholders. NRBO Old's management efficiency ratios could be used to measure how well NRBO Old manages its routine affairs as well as how well it operates its assets and liabilities.NRBO Old currently holds 203 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. NRBO Old has a current ratio of 7.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about NRBO Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Tomasz George | Virax Biolabs Group | 40 | |
| Jason Davis | Virax Biolabs Group | 53 | |
| Brian Strem | Kiora Pharmaceuticals | 46 | |
| Quan Vu | 180 Life Sciences | 52 | |
| John Cini | Sonnet Biotherapeutics Holdings | 72 | |
| Michael Myers | Quoin Pharmaceuticals Ltd | 63 | |
| Gordon JD | Quoin Pharmaceuticals Ltd | 61 | |
| Jason Assad | 180 Life Sciences | N/A | |
| Chester III | Revelation Biosciences | 45 | |
| Dr MedSc | Phio Pharmaceuticals Corp | 68 | |
| Joan Brown | Allarity Therapeutics | 70 | |
| MD DrSc | Allarity Therapeutics | 81 | |
| James Foster | Virax Biolabs Group | 40 | |
| Annie Rasmussen | Allarity Therapeutics | 67 | |
| Raphael Mechoulam | 180 Life Sciences | N/A | |
| Denise Carter | Quoin Pharmaceuticals Ltd | 56 | |
| Jonathan Rothbard | 180 Life Sciences | 71 | |
| Carol Odle | Revelation Biosciences | N/A | |
| MD FACP | Sonnet Biotherapeutics Holdings | 67 | |
| Claus Pedersen | Allarity Therapeutics | 52 | |
| Manuel Dafonseca | Sonnet Biotherapeutics Holdings | N/A | |
Management Performance
| Return On Equity | -1.61 | |||
| Return On Asset | -0.74 |
NRBO Old Leadership Team
Elected by the shareholders, the NRBO Old's board of directors comprises two types of representatives: NRBO Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NRBO. The board's role is to monitor NRBO Old's management team and ensure that shareholders' interests are well served. NRBO Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NRBO Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| PharmD BCPS, VP Operations | ||
| Marshall Woodworth, Principal CFO | ||
| HyungHeon Kim, President CEO | ||
| Robert Homolka, Senior Operations | ||
| Ben MD, CEO Pres | ||
| Frank Kondrad, VP Devel | ||
| MiKyung Kim, Chief Officer |
NRBO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NRBO Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.61 | |||
| Return On Asset | -0.74 | |||
| Current Valuation | (1.18 M) | |||
| Shares Outstanding | 8.62 M | |||
| Shares Owned By Insiders | 65.23 % | |||
| Shares Owned By Institutions | 12.71 % | |||
| Number Of Shares Shorted | 34.27 K | |||
| Price To Earning | (1.44) X | |||
| Price To Book | 1.57 X | |||
| Revenue | 7 K |
Pair Trading with NRBO Old
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NRBO Old position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRBO Old will appreciate offsetting losses from the drop in the long position's value.Moving together with NRBO Stock
Moving against NRBO Stock
| 0.78 | NVRO | Nevro Corp | PairCorr |
| 0.78 | GE | GE Aerospace | PairCorr |
| 0.76 | IBM | International Business | PairCorr |
| 0.75 | T | ATT Inc Earnings Call This Week | PairCorr |
| 0.73 | JNJ | Johnson Johnson | PairCorr |
The ability to find closely correlated positions to NRBO Old could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NRBO Old when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NRBO Old - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NRBO Old to buy it.
The correlation of NRBO Old is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NRBO Old moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NRBO Old moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NRBO Old can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in NRBO Stock
If you are still planning to invest in NRBO Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NRBO Old's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |